おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
imvaria
company
About
Empower clinicians to make the best decisions
- 11 - 50
Highlights
Details
- Last Funding Type
- Seed
- Industries
- Health Care,Health Diagnostics,Medical Device
- Founded date
- Jan 1, 2019
- Number Of Employee
- 11 - 50
- Operating Status
- Active
imvaria was founded in 2019 by a team of physician-engineers from Stanford and Google, seeking to empower clinicians and improve patient outcomes through the development and application of modern computer science techniques to complex and serious diseases. The company's Digital Biomarker Platform enables non-invasive diagnostic and therapeutic patient stratification via data science and machine learning.imvaria's lead software effort is assigned FDA's Breakthrough Device Designation.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
imvaria has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Apr 30, 2020 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 30, 2020 | Seed | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
imvaria is funded by 1 investors.
Cloudstone Venture
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
